OSR Health Warrant
OSRHW
26 hedge funds and large institutions have $3.51M invested in OSR Health Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
7% less funds holding
Funds holding: 28 → 26 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
38% less capital invested
Capital invested by funds: $5.65M → $3.51M (-$2.14M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$15.1K |
| 2 |
ASM
ATW SPAC Management
New York
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.2M |
| 2 |
EAM
Exos Asset Management
New York
|
-$4K |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$246 |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$156 |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$118 |
OSRHW Hedge Fund Activity: Q3 2024 in Review
26 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q3 2024, worth a combined $3.51M — down 38% from $5.65M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of OSRHW and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Cowen and Company, adding an estimated $15.1K. The largest seller was Mangrove Partners, exiting entirely with an estimated $2.2M sold.
- 26 institutional investors held OSR Health Warrant (OSRHW) as of Q3 2024, down from 28 in Q2 2024.
- Funds reported $3.51M of OSR Health Warrant stock for Q3 2024, down 38% quarter-over-quarter.
- 2 funds opened new OSR Health Warrant positions in Q3 2024 and 3 closed out, a net change of -1 holder.
- The largest OSR Health Warrant buyer in Q3 2024 was Cowen and Company, an estimated $15.1K added.
- The largest OSR Health Warrant seller in Q3 2024 was Mangrove Partners, an estimated $2.2M sold.
Based on aggregated 13F filings for Q3 2024.